Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step catalytic method for pyrido-pyrimidinones. Reduces synthetic steps, improves yield, and ensures supply chain stability for high-purity pharmaceutical intermediates.
Patent CN107954936A reveals a high-yield synthesis route for deuterated imidazole diketone compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104031029A reveals a one-step synthesis for bepotastine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104884450B details a novel copper-catalyzed route for Voriconazole intermediates offering significant supply chain and cost advantages for global pharmaceutical manufacturers.
Novel Rh-catalyzed hydrosilylation patent CN108586512A offers high yield Z-beta vinyl silanes. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediate manufacturing.
Novel ionic liquid method enhances cinacalcet hydrochloride purity and yield offering significant supply chain stability and cost reduction advantages for pharmaceutical manufacturing.
Patent CN115246761B reveals metal-free synthesis for polysubstituted naphthalene derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover the advanced Rh-catalyzed C-H olefination method for synthesizing pyrrole ethylene derivatives. A reliable solution for high-purity pharmaceutical intermediates manufacturing.
Efficient Pd-catalyzed intramolecular amination route for 2-trifluoromethyl indoles offering high purity and scalable manufacturing for pharma intermediates.
Patent CN115246815A details a novel nicotine preparation method recycling chiral resolution waste, offering high purity and reduced environmental impact for pharmaceutical manufacturers.
Novel patent CN117447387A enables cost-effective chiral intermediate production. Enhances supply chain reliability and purity for global API manufacturing partners.
Patent CN116082181B reveals a cost-effective synthesis route for Alzheimer's intermediates. Achieve high purity without column purification for scalable supply.
Patent CN111004212A reveals high-yield nicotine synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel asymmetric synthesis of Beclabuvir intermediate via chiral copper catalysis. High yield, >99% ee, scalable process for API manufacturing.
Novel Raney Nickel catalytic method improves yield and reduces cost for capsaicinoid intermediates. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN107602412A details a novel purification method for aldehyde oil methanol solution enhancing purity and solvent recovery for sustainable sulphadiazine intermediate manufacturing supply chains.
Novel liquid-phase synthesis method for high-purity kappa opioid agonist intermediates, offering significant cost and purity advantages over solid-phase methods.
Novel patent CN111057031A details efficient benzofuranone preparation. Offers supply chain stability and cost reduction for agrochemical and pharmaceutical manufacturing.
Novel green synthesis of Dapoxetine from acetophenone. Improved yield, reduced waste, scalable industrial process for pharmaceutical intermediates.
Patent CN111362807B details a green aerobic oxidation route for 3-nitro-2-methylbenzoic acid, offering high purity and reduced waste for pharmaceutical supply chains.